https://www.marketscreener.com/quote/stock/AKESO-INC-111325370/news/NMPA-Accepts-Akeso-s-Ebronucimab-PCSK9-Marketing-Application-in-Two-Cardiovascular-Indications-44023488/?utm_source=telegram&utm_medium=social&utm_campaign=share